Stock Events

Stock Events

Corline Biomedical AB 

€1.2200
0
+€0.04+3.83% 08:06 Today

Statistics

Day High
1.22
Day Low
1.22
52W High
1.715
52W Low
1.175
Volume
-
Avg. Volume
-
Mkt Cap
31.88M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 19Expected
Q4 2025
Q1 2026
Q2 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-192.47%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
698,156.21Revenue
-1.34MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Xencor
XNCR
Mkt Cap2.22B
Xencor Inc. develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, which competes with Corline's renal and cardiovascular biocompatibility products.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals, Inc. specializes in immunology and inflammatory conditions, directly competing with Corline's focus on enhancing biocompatibility in transplantation and vascular surgery.
Macrogenics
MGNX
Mkt Cap152.88M
MacroGenics Inc. focuses on creating antibody-based therapeutics for the treatment of cancer and autoimmune disorders, overlapping with Corline's therapeutic areas.
Summit Therapeutics
SMMT
Mkt Cap12.79B
Summit Therapeutics operates in advancing new therapies in the areas like Duchenne Muscular Dystrophy and C. difficile infection, which competes indirectly by targeting similar therapeutic mechanisms.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.33B
BioMarin Pharmaceutical Inc. develops enzyme replacement therapies, competing in the broader biopharmaceutical sector focused on complex biological mechanisms similar to Corline.
Ultragenyx Pharmaceutical
RARE
Mkt Cap1.59B
Ultragenyx Pharmaceutical Inc. works on rare genetic diseases treatment, competing in the niche market of specialized biopharmaceuticals similar to Corline's targeted therapeutic areas.
CRISPR Therapeutics
CRSP
Mkt Cap4.97B
CRISPR Therapeutics AG is involved in gene editing technologies, which could potentially overlap or compete with Corline's biocompatible coating technologies in future applications.

About

Corline Biomedical AB is a company dedicated to the creation, production, and distribution of heparin-based solutions. These solutions are specifically engineered to enhance outcomes in kidney transplantation, cellular therapies, and regenerative medicine. At the heart of their product line is the proprietary Corline Heparin Conjugate (CHC) technology, a unique heparin conjugate that can function as a standalone pharmaceutical compound. The company's diverse portfolio includes Renaparin, aimed at treating end-stage renal failure; Cytoparin, a cell therapy designed for patients with type 1 diabetes; the CHC compound itself for addressing soft tissue injuries; and a variety of medical devices, such as CHS, a coronary stent. Established in 1991, Corline Biomedical AB operates from its headquarters in Uppsala, Sweden.
Show More
CEO
Henrik Nittmar
Employees
14
Country
Sweden
ISIN
SE0006887451
WKN
000A2JJ8B

Listings

F
DE
IZ7.F
ST
SE
CLBIO-BTA.ST
ST
SE
CLBIO.ST

0 Comments

Share your thoughts

FAQs

What is Corline Biomedical AB stock price today?▼
The current price of IZ7.F is €1.22 EUR — it has increased by +3.83% in the past 24 hours. Watch Corline Biomedical AB stock price performance more closely on the chart.
What is Corline Biomedical AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Corline Biomedical AB stocks are traded under the ticker IZ7.F.
What is Corline Biomedical AB market cap?▼
Today Corline Biomedical AB has the market capitalization of 31.88M
When is the next Corline Biomedical AB earnings date?▼
Corline Biomedical AB is going to release the next earnings report on November 19, 2026.
What is Corline Biomedical AB revenue for the last year?▼
Corline Biomedical AB revenue for the last year amounts to 698,156.21 EUR.
What is Corline Biomedical AB net income for the last year?▼
IZ7.F net income for the last year is -1.34M EUR.
How many employees does Corline Biomedical AB have?▼
As of November 3, 2026, the company has 14 employees.
In which sector is Corline Biomedical AB located?▼
Corline Biomedical AB operates in the Health & Wellness sector.
When did Corline Biomedical AB complete a stock split?▼
Corline Biomedical AB has not had any recent stock splits.
Where is Corline Biomedical AB headquartered?▼
Corline Biomedical AB is headquartered in Uppsala, Sweden.